Potentially Clinically Significant Drug-Drug Interactions in Older Adults with Atrial Fibrillation and Multimorbidity: Prevalence, Correlates, and Association with Adverse Clinical Outcomes in a Swedish National Register-Based Study
Potentially clinically significant DDIs were prevalent in older adults with AF and multimorbidity, with adverse clinical implications. Identifying these high-risk groups is essential for preventive strategies and effective clinical management.
Authors
- Cheïma Amrouch (ORCID: https://orcid.org/0000-0001-6708-7372)
- Jonas W. Wastesson (ORCID: https://orcid.org/0000-0001-7601-4319)
- Antoneta Granic (ORCID: https://orcid.org/0000-0001-9247-899X)
- Ine Simal (ORCID: https://orcid.org/0009-0007-9570-2433)
- Amaia Calderón-Larrañaga
- Astrid D. H. Brys
- Gregory Y. H. Lip
- Cecilia Damiano
- Davide Liborio Vetrano
- Mirko Petrovic
- Dirk De Bacquer
- Delphine De Smedt
- Søren P. Johnsen
- Lu Dai
- Nicola Ferri
Institutions
- University of Padua (IT)
- University of Liverpool (GB)
- Stockholm University (SE)
- Istituto Superiore di Sanità (IT)
- Swedish Institute of International Affairs (SE)
- Ghent University Hospital (BE)
- Karolinska Institutet (SE)
- Ghent University (BE)
- Liverpool Heart and Chest Hospital (GB)
- Stockholm Gerontology Research Center Foundation (SE)
- Liverpool John Moores University (GB)
- Aalborg University (DK)
Publication Details
- Journal
- Cardiovascular Drugs and Therapy
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1007/s10557-025-07825-8
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission